Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 12391360.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cerebral cholesterol metabolism has been linked with production of amyloid peptide (Abeta) crucial in AD. The association between use of cholesterol-lowering drugs (statins) and AD disease is currently being intensely discussed. In this case-control study on elderly nondemented subjects, the authors provide the first evidence that statins in clinically relevant dosages indeed affect cerebral cholesterol metabolism. However, these changes were not associated with altered intrathecal secretion of Alzheimer Abeta.
Medical subject headings
- Alzheimer Disease
- Amyloid beta-Peptides
- Anticholesteremic Agents
- Cerebral Cortex
- Cholesterol
- Peptide Fragments